Tetratherix Overview

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • TTX

Stock Symbol

  • Share Price
  • $4.36
  • (As of Friday Closing)

Tetratherix General Information

Description

Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications, including Bone Regeneration, Tissue Spacing and Tissue Healing.

Contact Information

Website
www.tetratherix.com
Formerly Known As
Trimph
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Unit 29
  • 34-36 Ralph Street
  • Alexandria, New South Wales 2015
  • Australia
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
ASX
Vertical(s)
Life Sciences
Corporate Office
  • Unit 29
  • 34-36 Ralph Street
  • Alexandria, New South Wales 2015
  • Australia

Tetratherix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetratherix Stock Performance

As of 13-Nov-2026, Tetratherix’s stock price is $4.36. Its current market cap is $232M with 53.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.36 $4.38 $2.07 - $5.69 $232M 53.2M 22K

Tetratherix Financials Summary

As of 30-Sep-2026, Tetratherix has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 217,252 211,866 80,316
Revenue 622
EBITDA (5,844) (6,052) (2,828)
Net Income (6,314) (6,099) (2,962)
Total Assets 36,589 20,793
Total Debt 7,548 1,333 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tetratherix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tetratherix‘s full profile, request access.

Request a free trial

Tetratherix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Tetratherix‘s full profile, request access.

Request a free trial

Tetratherix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tetratherix FAQs

  • Where is Tetratherix headquartered?

    Tetratherix is headquartered in Alexandria, Australia.

  • What is the size of Tetratherix?

    Tetratherix has 20 total employees.

  • What industry is Tetratherix in?

    Tetratherix’s primary industry is Biotechnology.

  • Is Tetratherix a private or public company?

    Tetratherix is a Public company.

  • What is Tetratherix’s stock symbol?

    The ticker symbol for Tetratherix is TTX.

  • What is the current stock price of Tetratherix?

    As of 13-Nov-2026 the stock price of Tetratherix is $4.36.

  • What is the current market cap of Tetratherix?

    The current market capitalization of Tetratherix is $232M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process